A new tool will allow researchers to identify proteins involved in DNA replication and damage repair, processes that go awry in cancer.

New information about signaling pathways involved in colorectal cancer could aid in assessing prognosis and identifying new therapeutic targets for the disease.

A molecule detectable in urine may be helpful in diagnosing colon cancer.

Some patients may need a combo of medications to combat a condition that causes dizziness.

Abnormal levels of fatty acids in the blood and tissues of patients with cystic fibrosis may be reversed by supplementation with the fatty acids DHA and EPA.

New details on the DNA-cutting activity of topoisomerase II, a target of anti-cancer drugs, could lead to better chemotherapeutic agents.

An inexpensive, low-tech test for cervical cancer may be a good option for screening for the disease among HIV-infected women in developing countries.